3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Topiramate (toe-PYRE-a-mate) is used to help control some types of seizures in the treatment of epilepsy. This medicine cannot cure epilepsy and will only work to help control seizures for as long as you continue to take it.


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > Cancer -

Earlier diagnosis of ovarian cancer possible

CancerOct 29, 05

Symptoms associated with ovarian cancer, especially abdominal bloating and pain, often start several months prior to diagnosis, a study shows, suggesting that with appropriate testing the diagnosis can be made earlier than it is currently. Ovarian cancer is much more curable when detected early.

In the October 1st issue of Cancer, the study team says their observations “provide objective evidence that patients with ovarian cancer, as a group, are distinguishable symptomatically from controls at least 6 months prior to diagnosis.”

Dr. Lloyd H. Smith from the University of California Davis Health System in Sacramento and colleagues documented the pattern of symptoms and associated diagnostic tests prior to the diagnosis among nearly 1,900 women found to have ovarian cancer. The team did the same for roughly 6,000 women with Breast cancer, and 11,000 women without cancer.

According to Smith, women with ovarian cancer were much more likely than women with Breast cancer and cancer-free women to have “target symptoms,” particularly abdominal swelling and pain more than 6 months before they were diagnosed with ovarian cancer.

Also, while abdominal imaging and pelvic imaging with CA125 testing were often used within the 3 months prior to diagnosis of ovarian cancer, relatively few patients had such studies 4 to 36 months prior to diagnosis, the authors report. CA125 is a protein known to be elevated in patients with ovarian cancer.

Smith said it’s also worth noting that among women with ovarian cancer, “those who had diagnostic testing usually had abdominal imaging or gastrointestinal procedures, rather than pelvic imaging/CA125 determination.”

“Our findings suggest that ovarian cancer could be diagnosed earlier in some patients whose diagnosis is currently delayed by at least 4 months, because physicians order abdominal imaging or perform gastrointestinal procedures before they order a test that is more likely to diagnose ovarian cancer, such as pelvic imaging and/or CA125,” the authors write.

Smith advises women with symptoms suggestive of ovarian cancer to “seek a routine medical evaluation.” Pelvic imaging and CA125 screening “should be considered” in women with target symptoms of ovarian cancer that persist and are unexplained,” Smith said.

SOURCE: Cancer October 1, 2005.



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Latinas more likely to regret breast cancer treatment decisions
  Cancer survival rates impact type of Web communities used by patients
  No Protective Effect on Cancer from Long-Term Vitamin E or Vitamin C Supplementation
  Genetics of aging and cancer resistance
  Scientists unravel breast cancer drug resistance
  The Relative Risk of Brain Cancer
  How women can improve their quality of life after breast cancer treatment
  Review examines breast cancer prevention strategies in the United States
  Folic Acid, B Vitamins Do Not Appear to Affect Cancer Risk
  If the diabetes has a direct carcinogenetic effect?
  Prostate cancer not warded off by supplements
  Don’t Forget the Men in October’s Sea of Pink

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site